Telos Capital Management Inc. Has $2.58 Million Stock Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Telos Capital Management Inc. cut its position in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 1.0% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 26,106 shares of the exchange traded fund’s stock after selling 270 shares during the period. Telos Capital Management Inc.’s holdings in SPDR S&P Biotech ETF were worth $2,579,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. Fifth Third Bancorp raised its holdings in SPDR S&P Biotech ETF by 3.4% in the second quarter. Fifth Third Bancorp now owns 118,303 shares of the exchange traded fund’s stock worth $10,968,000 after purchasing an additional 3,922 shares during the period. RFG Advisory LLC acquired a new stake in SPDR S&P Biotech ETF in the first quarter worth $219,000. Avantax Advisory Services Inc. raised its holdings in SPDR S&P Biotech ETF by 17.2% in the first quarter. Avantax Advisory Services Inc. now owns 9,619 shares of the exchange traded fund’s stock worth $913,000 after purchasing an additional 1,415 shares during the period. PFG Investments LLC raised its holdings in SPDR S&P Biotech ETF by 9.2% in the second quarter. PFG Investments LLC now owns 24,844 shares of the exchange traded fund’s stock worth $2,303,000 after purchasing an additional 2,097 shares during the period. Finally, Brookstone Capital Management acquired a new stake in SPDR S&P Biotech ETF in the first quarter worth $284,000.

SPDR S&P Biotech ETF Stock Performance

XBI opened at $98.15 on Tuesday. The firm’s fifty day moving average is $99.08 and its two-hundred day moving average is $94.40. The firm has a market cap of $7.48 billion, a PE ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a twelve month low of $63.80 and a twelve month high of $103.52.

SPDR S&P Biotech ETF Company Profile

(Free Report)

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Further Reading

• Five stocks we like better than SPDR S&P Biotech ETF
• What Are the FAANG Stocks and Are They Good Investments?
• Is CoStar Group Stock a Buy Before Earnings? Analysts Think So
• Stock Ratings and Recommendations: Understanding Analyst Ratings
• 3 Stocks Driving the Shift to Nuclear Energy for AI Power
• The Basics of Support and Resistance
• Utilities Outperform in 2024: 3 Stocks to Keep on Your Radar

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).